Unknown

Dataset Information

0

Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications.


ABSTRACT: We have recently described manufacturing of human induced pluripotent stem cells (iPSC) master cell banks (MCB) generated by a clinically compliant process using cord blood as a starting material (Baghbaderani et al. in Stem Cell Reports, 5(4), 647-659, 2015). In this manuscript, we describe the detailed characterization of the two iPSC clones generated using this process, including whole genome sequencing (WGS), microarray, and comparative genomic hybridization (aCGH) single nucleotide polymorphism (SNP) analysis. We compare their profiles with a proposed calibration material and with a reporter subclone and lines made by a similar process from different donors. We believe that iPSCs are likely to be used to make multiple clinical products. We further believe that the lines used as input material will be used at different sites and, given their immortal status, will be used for many years or even decades. Therefore, it will be important to develop assays to monitor the state of the cells and their drift in culture. We suggest that a detailed characterization of the initial status of the cells, a comparison with some calibration material and the development of reporter sublcones will help determine which set of tests will be most useful in monitoring the cells and establishing criteria for discarding a line.

SUBMITTER: Baghbaderani BA 

PROVIDER: S-EPMC4919381 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications.

Baghbaderani Behnam Ahmadian BA   Syama Adhikarla A   Sivapatham Renuka R   Pei Ying Y   Mukherjee Odity O   Fellner Thomas T   Zeng Xianmin X   Rao Mahendra S MS  

Stem cell reviews and reports 20160801 4


We have recently described manufacturing of human induced pluripotent stem cells (iPSC) master cell banks (MCB) generated by a clinically compliant process using cord blood as a starting material (Baghbaderani et al. in Stem Cell Reports, 5(4), 647-659, 2015). In this manuscript, we describe the detailed characterization of the two iPSC clones generated using this process, including whole genome sequencing (WGS), microarray, and comparative genomic hybridization (aCGH) single nucleotide polymorp  ...[more]

Similar Datasets

| S-EPMC4624993 | biostudies-literature
| S-EPMC6828592 | biostudies-literature
| S-EPMC6316689 | biostudies-literature
| S-EPMC6485183 | biostudies-literature
| S-EPMC3467279 | biostudies-literature
| S-EPMC9368986 | biostudies-literature
| S-EPMC7557348 | biostudies-literature
| S-EPMC6474585 | biostudies-literature
| S-EPMC4042300 | biostudies-other
| S-EPMC5822467 | biostudies-literature